AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 8, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	211,618	215,159	133,010	81,183	63,886	75,255
Market Cap Growth	30.11%	61.76%	63.84%	27.07%	-15.11%	25.87%
Enterprise Value	207,966	210,362	127,861	76,552	60,484	72,857
Last Close Price	8464.50	8578.33	5292.42	3217.09	2516.97	2966.26
PE Ratio	106.26	185.90	82.35	81.76	103.71	80.66
PS Ratio	10.55	12.54	10.27	8.09	7.93	9.25
PB Ratio	26.49	27.93	18.68	13.79	12.49	16.50
P/TBV Ratio	26.49	27.95	18.74	13.79	12.49	16.50
P/FCF Ratio	-	338.25	777.38	163.12	70.07	77.53
P/OCF Ratio	-	329.19	477.25	139.27	63.38	71.82
EV/Sales Ratio	10.37	12.26	9.87	7.63	7.51	8.96
EV/EBITDA Ratio	65.19	84.67	69.81	47.45	73.16	54.94
EV/EBIT Ratio	75.74	97.93	74.58	51.43	87.20	62.67
EV/FCF Ratio	-517.84	330.71	747.29	153.81	66.33	75.06
Debt / Equity Ratio	0.04	0.05	0.01	0.01	0.02	0.03
Debt / EBITDA Ratio	0.11	0.14	0.02	0.04	0.10	0.09
Debt / FCF Ratio	-	0.56	0.27	0.14	0.10	0.13
Asset Turnover	1.41	1.32	1.26	1.09	0.99	1.10
Inventory Turnover	1.95	2.50	2.87	2.22	2.11	1.85
Quick Ratio	0.80	1.05	1.89	1.61	1.64	1.46
Current Ratio	1.87	1.91	2.61	2.18	2.12	2.04
Return on Equity (ROE)	26.94%	15.62%	24.84%	18.05%	12.73%	22.74%
Return on Assets (ROA)	12.02%	10.34%	10.39%	10.11%	5.32%	9.81%
Return on Capital (ROIC)	22.43%	17.64%	16.33%	16.67%	8.77%	17.21%
Return on Capital Employed (ROCE)	32.80%	26.40%	23.80%	24.80%	13.20%	24.70%
Earnings Yield	0.94%	0.54%	1.21%	1.22%	0.96%	1.24%
FCF Yield	-0.19%	0.30%	0.13%	0.61%	1.43%	1.29%
Dividend Yield	0.38%	0.37%	0.45%	0.50%	0.40%	0.07%
Payout Ratio	40.17%	51.84%	24.77%	20.14%	8.12%	5.36%
Total Shareholder Return	0.39%	0.37%	0.45%	0.50%	0.40%	0.07%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.